EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antibacterial agents in preclinical and clinical development

Timothy Jesudason

The Lancet Microbe · 2024

DOI: 10.1016/j.lanmic.2024.100962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Lancet Microbe, 2024. Verfasst von Timothy Jesudason. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Development. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On June 14, 2024, WHO published a global report on antibacterial agents in preclinical and clinical development. The resource provides an update to the WHO antibacterial pipeline analysis report in 2022 and includes both traditional and non-traditional antibacterial agents currently in development worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDrug DevelopmentHumansAnimalsDrug Evaluation, PreclinicalBacterial InfectionsClinical Trials as TopicBacteria

Substanzen

Anti-Bacterial Agents

Zitieren

APA

Jesudason, T. (2024). Antibacterial agents in preclinical and clinical development. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2024.100962

Vancouver

Jesudason T. Antibacterial agents in preclinical and clinical development. The Lancet Microbe. 2024. doi:10.1016/j.lanmic.2024.100962

BibTeX
@article{Jesudason2024,
  author = {Jesudason, Timothy},
  title = {Antibacterial agents in preclinical and clinical development},
  journal = {The Lancet Microbe},
  year = {2024},
  doi = {10.1016/j.lanmic.2024.100962}
}
Kostenlos starten →